Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Chimeric Therapeutics Ltd. is set to hold an Extraordinary General Meeting on December 4, 2024, both in-person and online, offering shareholders the chance to engage actively in the company’s strategic discussions. This meeting presents an opportunity for investors to stay informed and potentially influence the company’s future directions. Shareholders can participate virtually via a webcast or submit their votes using a proxy form.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.